Bristol-Myers Squibb Company (NYSE: BMY) and Otsuka Pharmaceutical Co., Ltd. today announced the launch of ABILIFY(R) (aripiprazole) Injection, an injectable form of ABILIFY, for intramuscular use. ABILIFY Injection provides rapid control of agitation in adults with schizophrenia or bipolar mania a...
read more »
Source:http://www.medicalnewstoday.com
Discuss Bury
Source:http://www.medicalnewstoday.com
Discuss Bury
Lead chelation therapy -- a chemical treatment to remove lead from the body -- can significantly reduce learning and behavioral problems that result from lead exposure, a Cornell study of young rats finds. [click link for full article]
read more »
Source:http://www.medicalnewstoday.com
Discuss Bury
Source:http://www.medicalnewstoday.com
Discuss Bury
Medinews is an online community dedicated for promoting and discussing latest medical news, research articles and blogs. You can also find regular updates on health news for discussion by health professionals.
